poisar

Stock

HealthEquity, Inc. HQY

$104.73-0.81%

Overview

HQY market data

Price History

HQY price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
37.92
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$2.46
Diluted earnings per share over the trailing twelve months.
Beta
0.24
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
17.3%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$72.76 – $107.62
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $8.7B · P/B 3.53 · P/S 6.54.

Company News

9 captured
BTIG Maintains Buy on HealthEquity, Raises Price Target to $115Benzinga · Jul 24, 2026, 10:24 AM
One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research FindsGlobenewswire Inc · Jun 8, 2026, 4:15 PM
RBC Capital Reiterates Outperform on HealthEquity, Maintains $108 Price TargetBenzinga · Jun 3, 2026, 4:00 PM
Citizens Maintains Market Outperform on HealthEquity, Raises Price Target to $111Benzinga · Jun 1, 2026, 3:15 PM
RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $108Benzinga · May 29, 2026, 4:30 PM
HealthEquity Q1 2027 Earnings Call: Complete TranscriptBenzinga · May 28, 2026, 9:59 PM
HealthEquity Raises FY2027 GAAP EPS Guidance from $2.78-$2.85 to $2.88-$2.95 vs $2.84 EstBenzinga · May 28, 2026, 8:04 PM
HealthEquity Raises FY2027 Adj EPS Guidance from $4.56-$4.65 to $4.66-$4.73 vs $4.63 Est; Raises FY2027 Sales Guidance from $1.380B-$1.410B to $1.410B-$1.420B vs $1.411B EstBenzinga · May 28, 2026, 8:04 PM
HealthEquity Q1 Adj. EPS $1.24 Beats $1.11 Estimate, Sales $354.641M Beat $351.862M EstimateBenzinga · May 28, 2026, 8:02 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock